Discover the future of parenteral drug delivery through expert interviews and real-world insights. Explore innovative strategies and design approaches driving improvements in usability, patient experience, and treatment outcomes.
This article, authored by Steve Augustyn, featuring insights from Krai Chatamra, VP of Clinical Development at Intrance Medical Systems, explores the necessity of advanced therapies that provide consistent symptom control to improve patient outcomes and enable a more independent lifestyle.
Fran Pencliffe of Cambridge Design Partnership explores the benefits of platform devices for parenteral delivery and outlines the challenges, risks and best practices when bringing a combination product to market in this way.
The pharma industry’s move towards larger volumes of subcutaneous (SC) therapeutics and home-based care is increasing the demand for self-administration devices. We recently partnered with KORU to explore innovations in infusion pump technology aimed at enhancing patient comfort and convenience
We recently partnered with Re-Vana Therapeutics, pioneers in sustained-release technologies for a range of eye diseases. In this article, Re-Vana's Patrick H. O'Ruane, along with Cambridge Design Partnership's Dariusz Zak and Fran Pencliffe, discuss how advancing sustained-release therapies can help ease the burden of acute treatments.
We recently collaborated with Lent Innovations to explore critical issues in pediatric epinephrine injectors. Our latest article features insights from Dr. Annie Lent and our Deputy Head of Drug Delivery, Steve Augustyn.
Insights from Industry Experts on Training for Patient Technique, the Value of Connected Devices, and the Shift to Low GWP pMDIs.
Discover the exciting possibilities on the horizon for inhalation device design. Explore recent advancements and innovative strategies crucial for developing significant new treatments.
In a recent Q&A with Healthcare Packaging, CDP’s Clare Beddoes and Stephen Augustyn discuss the latest trends in on-body large volume injectors (LVIs) and what they expect to see in 2024.
Explore five exciting developments in the field of oncology and how advances in diagnostics, data analytics, cell biology and delivery devices are enabling oncology companies to bring the hope of longer, healthier lives.
Mark Allen, Andrew Fiorini, and Shai Assia discuss the need to develop delivery devices early when formulating nasally delivered drugs for systemic and local action, and a method by which the route to clinic can be made easier, faster and cheaper.
Sergio and Alejandra explore emerging implantable neuromodulation therapies that are opening new possibilities in the rapidly evolving field.